Investment Type: Venture Capital
Investment Stage: Seed
Portfolio 27
| Date | Name | Website | Total Raised | Location |
| 12.06.2024 | Kodikaz Th... | kodikaz.com | $255.8K | United Sta... |
| 10.01.2024 | Lario Ther... | lariotx.com | $6M | - |
| 08.11.2023 | Harness Th... | harnesstx.com | $5.09M | United Kin... |
| 09.12.2022 | Nyra Medic... | nyramed.com | $20M | United Sta... |
| 06.06.2022 | Transine T... | transinetx.com | $30.15M | United Kin... |
| 08.04.2022 | KynosTxLtd | kynostx.com | $11.76M | United Kin... |
| 10.11.2016 | Enterprise... | enterprisetherapeutics.com | $85.47M | United Kin... |
| - | LUNACtx | lunactherapeutics.com | - | United Kin... |
| - | Caldan The... | caldantherapeutics.com | - | United Kin... |
| - | Slate Bio,... | slatebio.com | $1.75M | United Sta... |
Show more
Mentions in press and media 25
| Date | Title | Description |
| 10.09.2024 | Epsilogen Secures £12.5 Million to Propel Cancer Treatment Innovations | Epsilogen, a pioneering force in the realm of immunoglobulin E (IgE) antibodies, has successfully raised £12.5 million in a Series B funding round. This brings the total Series B financing to an impressive £43.25 million. The funds will be ... |
| 09.09.2024 | Epsilogen: Immunoglobulin Development Company Raises £12.5 Million (Series B) | Epsilogen – a leader in the development of immunoglobulin E (IgE) antibodies to treat cancer – announced today the completion of a £12.5 million Series B expansion financing, bringing the Series B total to £43.25 million. The funding will a... |
| 21.10.2021 | VCs back Leucid to trial CAR-T twist in ovarian cancer patients | John Maher, Ph.D., has secured funding to put his ideas about CAR-Ts to the test. As chief scientific officer of Leucid Bio, Maher has pushed the idea that the configuration of co-stimulatory modules is the secret to success in CAR-T—and no... |
| 06.10.2021 | Starting a health technology company in Baltimore? Here are 43 resources to know | The digital health sector was growing rapidly. Then the pandemic came. In this case, it was a story of growth. Following distancing requirements and loosening regulations, telemedicine became the name of the game for many healthcare systems... |
| 23.06.2021 | RapidPulse Launches with $15M for Ischemic Stroke Therapy | – RapidPulse, Inc., a Miami-based medical device company developing a novel aspiration system to treat ischemic stroke, today announced it has raised $15M in Series A funding led by Santé Ventures who was joined by Epidarex Capital, Hattera... |
| 02.06.2021 | Baltimore’s startup community has a model. Now it needs to scale | Startups can’t stay in the early stage forever. While a young company can benefit from the early momentum of pitch wins and resources found in a community, it eventually must figure out its business model, and ultimately scale. Hearing lead... |
| 19.01.2021 | Slate Bio Closes $1.75 Million Seed Financing | Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Capital led the investment round with participation from the UVA Licensing & Ventures Group Seed Fund, Center for Innovative Technology’s GAP Bi... |
| 07.01.2021 | News briefing: Pfizer kickstarts PhIII trial for DMD gene therapy, outracing Sarepta; Teva's reformulated schizophrenia shot touts win in late-stage study | In the race to bring the first gene therapy for Duchenne muscular dystrophy into a Phase III trial, Pfizer has come out on top over competitor Sarepta, dosing its first patient in the CIFFREO study, the pharma giant said Th... |
| 16.10.2020 | Need startup funding? Here are 75+ venture capital firms in the Baltimore-DC region | If you’re located in New York City or the Silicon Valley, venture capital firms are abundant and well covered by the media — you can’t escape them. But entrepreneurs in the Baltimore-D.C. region don’t need to go so far to find a firm that c... |
| 13.10.2020 | Need startup funding? Here are 75+ venture capital firms in the DMV region | If you’re located in New York City or the Silicon Valley, venture capital firms are abundant and well covered by the media — you can’t escape them. But entrepreneurs in the DMV region don’t need to go so far to find a firm that could propel... |
Show more